Leandro Gatdula, CRNA | |
441 N Lakeview Ave, Anaheim, CA 92807-3028 | |
(888) 988-2800 | |
Not Available |
Full Name | Leandro Gatdula |
---|---|
Gender | Male |
Speciality | Nurse Anesthetist, Certified Registered |
Location | 441 N Lakeview Ave, Anaheim, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437218161 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | NA1027 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Leandro Gatdula, CRNA 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 | Leandro Gatdula, CRNA 441 N Lakeview Ave, Anaheim, CA 92807-3028 Ph: (888) 988-2800 |
News Archive
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
The recent announcement "that the Administration's signature Global Health Initiative (GHI) was being replaced by a new Office of Global Health Diplomacy at State was greeted with withering criticism from many in the global health community," PSI CEO Karl Hofmann writes in this post in the organization's "Healthy Lives" blog.
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain (16-20 Sept, 2019), and published simultaneously in The Lancet, is the first to show that early combination therapy using vildagliptin and metformin in patients newly diagnosed with type 2 diabetes (T2D) leads to better long-term blood sugar control and a reduced rate of treatment failure than metformin alone.
EffRx Pharmaceuticals SA, a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to its proprietary metformin-based product candidate, EX404, for the treatment of pediatric polycystic ovary syndrome (PCOS).
Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions - but this requires an injection.
› Verified 6 days ago
Laura Koh, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-2000 | |
Teresa Huang, RN, MSN, FNP, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3440 E La Palma Ave, Anaheim, CA 92806 Phone: 714-644-2000 | |
Carol J Wesner, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Carol A Dilibero, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4487 | |
Edward H Marthaler, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Susan M Heravi, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Tracy L Ouzounian, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 |